ACADIA Pharmaceuticals Inc. (ACAD) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

ACADIA Pharmaceuticals Inc. (ACAD) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

ACAD Income Statement

ACADIA Pharmaceuticals Inc. (ACAD) annual income statement — 25-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	342.29M	307.96M	268.06M	283.99M	278.63M	264.57M	244.32M	259.6M	250.4M	241.96M	205.83M	231.04M	211.7M	165.24M	118.46M	136.49M	130.71M	134.56M	115.47M	130.76M
Revenue Growth %	22.85%	16.4%	9.72%	9.39%	11.27%	9.34%	18.7%	12.36%	18.28%	46.44%	73.75%	69.27%	61.96%	22.79%	2.59%	4.38%	-0.68%	16.79%	8.37%	8.06%
Cost of Goods Sold	35.09M	28.32M	24.79M	26.23M	21.65M	20.73M	20.39M	21.8M	18.86M	18.23M	22.95M	17.89M	14.62M	7.46M	1.67M	2.41M	2.14M	2.67M	2.95M	2.56M
COGS % of Revenue	10.25%	9.19%	9.25%	9.23%	7.77%	7.84%	8.35%	8.4%	7.53%	7.53%	11.15%	7.74%	6.91%	4.51%	1.41%	1.77%	1.63%	1.98%	2.55%	1.96%
Gross Profit	307.2M	279.64M	243.27M	257.76M	256.99M	243.83M	223.93M	237.8M	231.54M	223.73M	182.88M	213.15M	197.08M	157.78M	116.8M	134.08M	128.58M	131.9M	112.52M	128.2M
Gross Margin %	89.75%	90.81%	90.75%	90.77%	92.23%	92.16%	91.65%	91.6%	92.47%	92.47%	88.85%	92.26%	93.09%	95.49%	98.59%	98.23%	98.37%	98.02%	97.45%	98.04%
Gross Profit Growth %	19.54%	14.69%	8.64%	8.4%	10.99%	8.98%	22.44%	11.56%	17.49%	41.8%	56.58%	58.98%	53.27%	19.62%	3.8%	4.59%	2.92%	19.89%	10.46%	10.8%
Operating Expenses	235.48M	241.81M	247.89M	240.37M	221.23M	211.46M	204.63M	84.3M	199.9M	193.3M	167.67M	178.21M	254.85M	154.74M	170.38M	180.14M	159.44M	165.55M	225.53M	172.85M
OpEx % of Revenue	68.8%	78.52%	92.47%	84.64%	79.4%	79.93%	83.76%	32.47%	79.83%	79.89%	81.46%	77.13%	120.38%	93.65%	143.83%	131.98%	121.98%	123.03%	195.32%	132.19%
Selling, General & Admin	159.2M	160.25M	171.02M	155.62M	133.4M	133.51M	126.37M	130.08M	133.29M	117.06M	107.99M	111.47M	97.89M	95.97M	101.23M	104.4M	78.11M	89.9M	96.68M	105.91M
SG&A % of Revenue	46.51%	52.04%	63.8%	54.8%	47.88%	50.46%	51.72%	50.11%	53.23%	48.38%	52.47%	48.24%	46.24%	58.08%	85.46%	76.49%	59.75%	66.81%	83.73%	81%
Research & Development	76.28M	81.56M	76.87M	84.76M	87.83M	77.95M	78.27M	100.73M	66.61M	76.23M	59.68M	66.74M	156.96M	58.77M	69.14M	75.74M	81.34M	75.65M	128.85M	66.94M
R&D % of Revenue	22.29%	26.48%	28.68%	29.85%	31.52%	29.46%	32.03%	38.8%	26.6%	31.51%	28.99%	28.89%	74.14%	35.57%	58.37%	55.49%	62.22%	56.22%	111.59%	51.2%
Other Operating Expenses	0	0	0	0	0	0	0	-1000K	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	71.72M	37.84M	-4.62M	17.39M	35.76M	32.37M	19.29M	153.5M	31.64M	30.44M	15.21M	34.94M	-57.78M	3.04M	-53.58M	-46.06M	-30.87M	-33.65M	-113.02M	-44.66M
Operating Margin %	20.95%	12.29%	-1.72%	6.12%	12.83%	12.24%	7.9%	59.13%	12.64%	12.58%	7.39%	15.12%	-27.29%	1.84%	-45.23%	-33.75%	-23.61%	-25.01%	-97.88%	-34.15%
Operating Income Growth %	100.58%	16.87%	-123.93%	-88.67%	12.99%	6.36%	26.82%	339.28%	154.77%	902.21%	128.39%	175.86%	-87.18%	109.02%	52.59%	-3.15%	-101.73%	23.01%	-69.26%	33.51%
EBITDA	80.44M	40.99M	-1.62M	20.32M	38.71M	35.31M	22.24M	158.72M	34.21M	33.01M	20.74M	36.58M	-56.05M	4.8M	-53.16M	-45.57M	-30.36M	-33.14M	-112.5M	-44.12M
EBITDA Margin %	23.5%	13.31%	-0.61%	7.15%	13.89%	13.35%	9.1%	61.14%	13.66%	13.64%	10.08%	15.83%	-26.48%	2.91%	-44.87%	-33.39%	-23.23%	-24.62%	-97.43%	-33.74%
EBITDA Growth %	107.82%	16.1%	-107.3%	-87.2%	13.13%	6.97%	7.25%	333.88%	161.04%	587.24%	139.01%	180.27%	-84.63%	114.49%	52.75%	-3.29%	-112.07%	22.54%	-70.77%	33.48%
D&A (Non-Cash Add-back)	0	3.16M	2.99M	2.92M	2.95M	2.94M	2.95M	5.21M	2.57M	2.57M	5.53M	1.64M	1.72M	1.77M	426K	489K	506K	515K	516K	535K
EBIT	80.44M	29.2M	3.98M	26.32M	44.59M	40.21M	27.78M	6.99M	38.81M	37.18M	21M	34.94M	-57.78M	3.04M	-53.58M	-46.06M	-30.87M	-33.65M	-113.02M	-44.66M
Net Interest Income	8.42M	7.99M	8.05M	8.33M	8.25M	7.24M	7.9M	7.01M	6.59M	6.36M	5.51M	4.76M	4.13M	4.55M	3.8M	3.63M	2.29M	580K	105K	129K
Interest Income	8.42M	7.99M	8.05M	8.33M	8.25M	7.24M	7.9M	7.01M	6.59M	6.36M	5.51M	4.76M	4.13M	4.55M	3.8M	3.63M	2.29M	580K	105K	129K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	8.72M	8.64M	8.6M	8.93M	8.84M	7.84M	8.49M	7.58M	7.16M	6.75M	5.79M	4.76M	5.63M	3.31M	8.64M	5.17M	4.45M	83K	445K	1.75M
Pretax Income	80.44M	46.47M	3.98M	26.32M	44.59M	40.21M	27.78M	161.09M	38.81M	37.18M	21M	39.7M	-52.14M	6.34M	-44.94M	-40.89M	-26.41M	-33.57M	-112.57M	-42.91M
Pretax Margin %	23.5%	15.09%	1.49%	9.27%	16%	15.2%	11.37%	62.05%	15.5%	15.37%	10.2%	17.18%	-24.63%	3.84%	-37.94%	-29.96%	-20.21%	-24.95%	-97.49%	-32.81%
Income Tax	26.91M	14.97M	344K	-247.25M	-27.18M	13.54M	8.79M	17.34M	6.04M	3.79M	4.45M	-6.09M	13.03M	5.23M	-1.92M	835K	768K	443K	485K	189K
Effective Tax Rate %	33.46%	32.22%	8.64%	-939.43%	-60.96%	33.68%	31.65%	10.77%	15.57%	10.2%	21.17%	-15.35%	-24.99%	82.44%	4.27%	-2.04%	-2.91%	-1.32%	-0.43%	-0.44%
Net Income	53.52M	31.5M	3.64M	273.57M	71.78M	26.67M	18.99M	143.74M	32.77M	33.39M	16.55M	45.8M	-65.18M	1.11M	-43.02M	-41.73M	-27.18M	-34.01M	-113.06M	-43.09M
Net Margin %	15.64%	10.23%	1.36%	96.33%	25.76%	10.08%	7.77%	55.37%	13.08%	13.8%	8.04%	19.82%	-30.79%	0.67%	-36.32%	-30.57%	-20.8%	-25.28%	-97.91%	-32.96%
Net Income Growth %	-25.43%	18.13%	-80.84%	90.32%	119.07%	-20.14%	14.69%	213.87%	150.27%	2897.22%	138.48%	209.76%	-139.77%	103.28%	61.95%	3.18%	-88.03%	22.48%	-70.14%	35.45%
Net Income (Continuing)	53.52M	31.5M	3.64M	273.57M	71.78M	26.67M	18.99M	143.74M	32.77M	33.39M	16.55M	45.8M	-65.18M	1.11M	-43.02M	-41.73M	-27.18M	-34.01M	-113.06M	-43.09M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.31	0.18	0.02	1.60	0.42	0.16	0.11	0.86	0.20	0.20	0.10	0.28	-0.40	0.01	-0.27	-0.26	-0.17	-0.21	-0.70	-0.27
EPS Growth %	-26.19%	12.5%	-81.82%	86.05%	110%	-20%	10%	207.14%	150%	-	137.04%	207.69%	-135.29%	103.24%	61.43%	3.7%	-88.89%	22.22%	-66.67%	35.71%
EPS (Basic)	0.31	0.18	0.02	1.62	0.43	0.16	0.11	0.86	0.20	0.20	0.10	0.28	-0.40	0.01	-0.27	-0.26	-0.17	-0.21	-0.70	-0.27
Diluted Shares Outstanding	175.47M	172.85M	172.71M	171.36M	170.65M	168.68M	167.67M	166.36M	166.18M	166.17M	166.62M	166.51M	164.23M	165.05M	162.26M	161.99M	161.85M	161.65M	161.23M	160.87M
Basic Shares Outstanding	172.54M	171.6M	170.52M	169.34M	168.84M	167.83M	166.81M	166.36M	165.97M	165.55M	164.8M	164.81M	164.23M	163.46M	162.26M	161.99M	161.85M	161.65M	161.23M	160.87M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-